Nektar Therapeutics (NKTR)
74.34
+0.65
(+0.88%)
USD |
NASDAQ |
Aug 25, 15:14
Nektar Therapeutics Total Assets (Quarterly) : 1.095B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.095B |
| March 31, 2026 | 763.27M |
| December 31, 2025 | 280.41M |
| September 30, 2025 | 301.35M |
| June 30, 2025 | 207.53M |
| March 31, 2025 | 256.24M |
| December 31, 2024 | 303.85M |
| September 30, 2024 | 307.97M |
| June 30, 2024 | 343.33M |
| March 31, 2024 | 396.01M |
| December 31, 2023 | 398.03M |
| September 30, 2023 | 442.24M |
| June 30, 2023 | 494.28M |
| March 31, 2023 | 561.74M |
| December 31, 2022 | 710.60M |
| September 30, 2022 | 781.01M |
| June 30, 2022 | 861.99M |
| March 31, 2022 | 1.024B |
| December 31, 2021 | 1.117B |
| September 30, 2021 | 1.277B |
| June 30, 2021 | 1.371B |
| March 31, 2021 | 1.457B |
| December 31, 2020 | 1.539B |
| September 30, 2020 | 1.509B |
| June 30, 2020 | 1.595B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.888B |
| December 31, 2019 | 1.977B |
| September 30, 2019 | 2.088B |
| June 30, 2019 | 2.100B |
| March 31, 2019 | 2.166B |
| December 31, 2018 | 2.150B |
| September 30, 2018 | 2.249B |
| June 30, 2018 | 2.313B |
| March 31, 2018 | 496.79M |
| December 31, 2017 | 508.87M |
| September 30, 2017 | 582.06M |
| June 30, 2017 | 475.86M |
| March 31, 2017 | 528.49M |
| December 31, 2016 | 568.87M |
| September 30, 2016 | 425.10M |
| June 30, 2016 | 463.10M |
| March 31, 2016 | 491.88M |
| December 31, 2015 | 502.06M |
| September 30, 2015 | 449.25M |
| June 30, 2015 | 456.67M |
| March 31, 2015 | 499.21M |
| December 31, 2014 | 441.62M |
| September 30, 2014 | 476.90M |
| June 30, 2014 | 478.14M |
| March 31, 2014 | 487.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Elite Pharmaceuticals, Inc. | 139.67M |
| Daré Bioscience, Inc. | 22.37M |
| Aclaris Therapeutics, Inc. | 179.69M |
| Eton Pharmaceuticals, Inc. | 115.81M |
| Journey Medical Corp. | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 192.01M |
| Shareholders Equity (Quarterly) | 903.12M |
| Debt to Equity Ratio | 0.1505 |
| Current Ratio | 10.42 |
| Net Debt Paydown Yield | 0.43% |